Generation Bio Co. (GBIO)
Generation Bio Statistics
Share Statistics
Generation Bio has 67.01M shares outstanding. The number of shares has increased by 0.72% in one year.
| Shares Outstanding | 67.01M |
| Shares Change (YoY) | 0.72% |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | 80.69% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 403 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 1.67M, so 2.5% of the outstanding shares have been sold short.
| Short Interest | 1.67M |
| Short % of Shares Out | 2.5% |
| Short % of Float | 3.64% |
| Short Ratio (days to cover) | 2.58 |
Valuation Ratios
The PE ratio is -0.54 and the forward PE ratio is -0.45. Generation Bio's PEG ratio is -0.53.
| PE Ratio | -0.54 |
| Forward PE | -0.45 |
| PS Ratio | 3.55 |
| Forward PS | 0.4 |
| PB Ratio | 0.82 |
| P/FCF Ratio | -0.78 |
| PEG Ratio | -0.53 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Generation Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.5, with a Debt / Equity ratio of 1.09.
| Current Ratio | 5.5 |
| Quick Ratio | 5.5 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | -1.26 |
| Debt / FCF | -1.03 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $172,973.91 |
| Profits Per Employee | $-1,144,939.13 |
| Employee Count | 115 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -85.85% in the last 52 weeks. The beta is 2.78, so Generation Bio's price volatility has been higher than the market average.
| Beta | 2.78 |
| 52-Week Price Change | -85.85% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 51.69 |
| Average Volume (20 Days) | 472,659 |
Income Statement
In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -1.98.
| Revenue | 19.89M |
| Gross Profit | 19.89M |
| Operating Income | -142.39M |
| Net Income | -131.67M |
| EBITDA | -74.26M |
| EBIT | -79.19M |
| Earnings Per Share (EPS) | -1.98 |
Balance Sheet
The company has 76.3M in cash and 93.56M in debt, giving a net cash position of -17.26M.
| Cash & Cash Equivalents | 76.3M |
| Total Debt | 93.56M |
| Net Cash | -17.26M |
| Retained Earnings | -703.04M |
| Total Assets | 231.2M |
| Working Capital | 157.85M |
Cash Flow
In the last 12 months, operating cash flow was -88.56M and capital expenditures -2.4M, giving a free cash flow of -90.96M.
| Operating Cash Flow | -88.56M |
| Capital Expenditures | -2.4M |
| Free Cash Flow | -90.96M |
| FCF Per Share | -1.37 |
Margins
Gross margin is 100%, with operating and profit margins of -715.82% and -661.91%.
| Gross Margin | 100% |
| Operating Margin | -715.82% |
| Pretax Margin | -661.91% |
| Profit Margin | -661.91% |
| EBITDA Margin | -373.33% |
| EBIT Margin | -715.82% |
| FCF Margin | -457.29% |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for GBIO is $8, which is 1718.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 1718.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | -4.36 |
| Piotroski F-Score | 3 |